Metastron and pyrexia Patient Reports February 13, 2012

Metastron Side Effects Report #5909590-0
Metastron side effect was reported by a Consumer or non-health professional from JAPAN on Sept 24, 2008. Male patient, 79 years of age, weighting 81.57 lb, was diagnosed with metastatic pain and was treated with Metastron. After drug was administered, patient experienced the following side effects: condition aggravated, delirium, pyrexia, red blood cell count decreased. Metastron dosage: unknown. Patient died on 08/26/2008.

Metastron Side Effects Report #6062315-3
Metastron side effect was reported by a Physician from JAPAN on Jan 22, 2009. Male patient, 79 years of age, weighting 81.57 lb, was diagnosed with metastatic pain and was treated with Metastron. After drug was administered, patient experienced the following side effects: bone marrow failure, delirium, disease progression, pyrexia. Metastron dosage: unknown. Patient recovered.

Metastron Side Effects Report #5874146-5
Metastron side effect was reported by a Consumer or non-health professional from JAPAN on Aug 20, 2008. Female patient, 58 years of age, weighting 77.82 lb, was diagnosed with metastatic pain and was treated with Metastron. After drug was administered, patient experienced the following side effects: bone pain, condition aggravated, hot flush, hypoaesthesia, metastases to bone, nausea , pyrexia. Metastron dosage: unknown. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient recovered.

Metastron Side Effects Report #6065532-1
Metastron side effect was reported by a Physician from JAPAN on Jan 22, 2009. Female patient, 58 years of age, weighting 77.82 lb, was diagnosed with metastatic pain and was treated with Metastron. After drug was administered, patient experienced the following side effects: bone pain, hot flush, hypoaesthesia, malignant neoplasm progression, metastases to bone, nausea , pyrexia. Metastron dosage: unknown. During the same period patient was treated with PACLITAXEL. Patient recovered.